You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 27, 2024

ZYRTEC-D 12 HOUR Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Zyrtec-d 12 Hour patents expire, and when can generic versions of Zyrtec-d 12 Hour launch?

Zyrtec-d 12 Hour is a drug marketed by J And J Consumer Inc and is included in one NDA.

The generic ingredient in ZYRTEC-D 12 HOUR is cetirizine hydrochloride; pseudoephedrine hydrochloride. There are thirty-nine drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the cetirizine hydrochloride; pseudoephedrine hydrochloride profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for ZYRTEC-D 12 HOUR?
  • What are the global sales for ZYRTEC-D 12 HOUR?
  • What is Average Wholesale Price for ZYRTEC-D 12 HOUR?
Drug patent expirations by year for ZYRTEC-D 12 HOUR
Recent Clinical Trials for ZYRTEC-D 12 HOUR

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Emory UniversityPhase 4
Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare DivisionPhase 1
Indiana UniversityPhase 4

See all ZYRTEC-D 12 HOUR clinical trials

Paragraph IV (Patent) Challenges for ZYRTEC-D 12 HOUR
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
ZYRTEC-D 12 HOUR Extended-release Tablets cetirizine hydrochloride; pseudoephedrine hydrochloride 5 mg/120 mg 021150 1 2004-06-02

US Patents and Regulatory Information for ZYRTEC-D 12 HOUR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
J And J Consumer Inc ZYRTEC-D 12 HOUR cetirizine hydrochloride; pseudoephedrine hydrochloride TABLET, EXTENDED RELEASE;ORAL 021150-002 Nov 9, 2007 OTC Yes Yes ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for ZYRTEC-D 12 HOUR

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
J And J Consumer Inc ZYRTEC-D 12 HOUR cetirizine hydrochloride; pseudoephedrine hydrochloride TABLET, EXTENDED RELEASE;ORAL 021150-002 Nov 9, 2007 6,469,009 ⤷  Subscribe
J And J Consumer Inc ZYRTEC-D 12 HOUR cetirizine hydrochloride; pseudoephedrine hydrochloride TABLET, EXTENDED RELEASE;ORAL 021150-002 Nov 9, 2007 7,226,614 ⤷  Subscribe
J And J Consumer Inc ZYRTEC-D 12 HOUR cetirizine hydrochloride; pseudoephedrine hydrochloride TABLET, EXTENDED RELEASE;ORAL 021150-002 Nov 9, 2007 6,489,329 ⤷  Subscribe
J And J Consumer Inc ZYRTEC-D 12 HOUR cetirizine hydrochloride; pseudoephedrine hydrochloride TABLET, EXTENDED RELEASE;ORAL 021150-002 Nov 9, 2007 7,014,867 ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for ZYRTEC-D 12 HOUR

See the table below for patents covering ZYRTEC-D 12 HOUR around the world.

Country Patent Number Title Estimated Expiration
Canada 1199918 ACIDES 2-[4-(DIPHENYLMETHYL)-1-PIPERAZINYL] ACETIQUES ET LEURS AMIDES (2-[4-(DIPHENYLMETHYL)-1-PIPERAZINYL]-ACETIC ACIDS AND THEIR AMIDES) ⤷  Subscribe
Costa Rica 7198 TABLETA QUE CONTIENE CETIRIZINA Y PSEUDOEFEDRINA ⤷  Subscribe
Luxembourg 90870 ⤷  Subscribe
Yugoslavia 43511 ⤷  Subscribe
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for ZYRTEC-D 12 HOUR

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0058146 SPC/GB01/052 United Kingdom ⤷  Subscribe SPC/GB01/052:, EXPIRES: 20070205
0663828 C300085 Netherlands ⤷  Subscribe PRODUCT NAME: LEVOCETIRIZINE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER LEVOCETIRINE DIHYDROCHLORIDE; NAT. REGISTRATION NO/DATE: RVG 26770 20011009; FIRST REGISTRATION: DE 49903.00.00 AND 49904.00.00 20010103
0058146 2001C/045 Belgium ⤷  Subscribe PRODUCT NAME: DICHLORHYDRATE DE LEVOCETIRIZINE; NAT RER. NO/DATE: 194 IS 90 F3 20011022; FIRST REG.: DE 49903.00.00 20010103
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

ZYRTEC-D 12 HOUR Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory of Zyrtec-D 12 Hour

Introduction

Zyrtec-D 12 Hour is a widely used over-the-counter (OTC) medication that combines the antihistamine cetirizine hydrochloride with the nasal decongestant pseudoephedrine hydrochloride. This dual-action formula provides relief from a range of allergy symptoms, including nasal congestion, sneezing, itchy eyes, and sinus pressure.

Market Demand and Growth

The demand for Zyrtec-D 12 Hour is driven by the prevalence of allergic rhinitis and other respiratory allergies. With a significant portion of the population suffering from seasonal and perennial allergies, the market for allergy medications remains robust.

  • Seasonal and Perennial Allergies: The high incidence of hay fever and other respiratory allergies ensures a consistent demand for effective allergy relief medications like Zyrtec-D 12 Hour[4].
  • Consumer Preference: The convenience of a dual-action formula that combines an antihistamine and a decongestant in one tablet enhances its appeal to consumers, contributing to its market growth[5].

Competitive Landscape

The allergy medication market is highly competitive, with several brands offering similar products. However, Zyrtec-D 12 Hour maintains a strong market position due to its proven efficacy and brand recognition.

  • Brand Recognition: Zyrtec is a well-established brand, and the addition of a decongestant in Zyrtec-D 12 Hour enhances its value proposition, making it a preferred choice for many consumers[4].
  • Competitors: Other notable competitors in the market include Claritin-D, Allegra-D, and Sudafed, but Zyrtec-D 12 Hour's unique formulation and marketing efforts help it stand out[2].

Pricing and Cost

The pricing of Zyrtec-D 12 Hour can vary depending on the retailer and any available discounts.

  • Retail Pricing: The average retail cost of Zyrtec-D 12 Hour is around $30 to $50 for a pack of 24 tablets, although prices can be lower with discount cards or promotions[2].
  • Discounts and Savings: Programs like SingleCare offer significant discounts, bringing the cost down to as low as $10 for 12-hour tablets, making the medication more accessible to a wider audience[2].

Insurance Coverage

Unlike some prescription medications, Zyrtec-D 12 Hour is generally not covered by insurance or Medicare Part D due to its OTC status.

  • OTC Status: Being available over the counter means that consumers typically pay out-of-pocket for Zyrtec-D 12 Hour, although it may be eligible for Flexible Spending Accounts (FSAs)[2][5].

Financial Performance

The financial performance of Zyrtec-D 12 Hour is influenced by its sales volume, pricing, and market share.

  • Sales Volume: With its widespread use and strong brand presence, Zyrtec-D 12 Hour generates significant revenue. The medication's ability to provide 12 hours of relief from allergy symptoms contributes to its high sales volume[5].
  • Market Share: As a leading brand in the allergy medication market, Zyrtec-D 12 Hour captures a substantial market share, which is a key factor in its financial success[4].

Consumer Behavior and Preferences

Consumer behavior plays a crucial role in the financial trajectory of Zyrtec-D 12 Hour.

  • Convenience and Efficacy: Consumers prefer medications that offer quick and effective relief. Zyrtec-D 12 Hour's dual-action formula and extended-release mechanism make it a preferred choice, driving sales and revenue[4][5].
  • Lifestyle Impact: The medication's ability to provide relief without significant drowsiness or other side effects that could impact daily activities is a major selling point, especially for busy professionals and students[4].

Regulatory and Safety Considerations

Regulatory and safety considerations can impact the market dynamics and financial performance of Zyrtec-D 12 Hour.

  • Contraindications and Precautions: The medication is contraindicated in patients with certain conditions, such as narrow-angle glaucoma, urinary retention, and hypertension. These contraindications can affect its market reach but also underscore the importance of proper usage and medical supervision[1][3].
  • Side Effects: Common side effects include drowsiness, headache, dizziness, and fatigue, as well as pseudoephedrine-specific side effects like insomnia and heart palpitations. Managing these side effects is crucial for maintaining consumer trust and market position[2][3].

Clinical Trials and Efficacy

The efficacy of Zyrtec-D 12 Hour has been established through clinical trials.

  • Clinical Trials: Multicenter, randomized, double-blind trials have shown that Zyrtec-D 12 Hour significantly reduces the Total Symptom Severity Complex (TSSC) score, which includes symptoms like sneezing, runny nose, itchy eyes, and nasal congestion[1][3].

Distribution and Availability

The availability of Zyrtec-D 12 Hour is widespread, making it easily accessible to consumers.

  • Retail Availability: The medication is available behind the pharmacy counter at various retail outlets, including pharmacies and online stores like Costco[5].

Key Takeaways

  • Strong Market Demand: Driven by the prevalence of allergic rhinitis and consumer preference for dual-action formulas.
  • Competitive Advantage: Zyrtec-D 12 Hour's brand recognition and proven efficacy set it apart in a competitive market.
  • Pricing and Discounts: Available at various price points with potential discounts through programs like SingleCare.
  • Financial Performance: Significant revenue generated due to high sales volume and market share.
  • Consumer Preferences: Convenience, efficacy, and minimal lifestyle impact are key drivers of consumer choice.
  • Regulatory Considerations: Important to adhere to contraindications and precautions to ensure safe usage.

Frequently Asked Questions

1. What is Zyrtec-D 12 Hour used for?

Zyrtec-D 12 Hour is used for the relief of nasal and non-nasal symptoms associated with seasonal or perennial allergic rhinitis, including sneezing, runny nose, itchy eyes, and sinus pressure[1][4].

2. How often should I take Zyrtec-D 12 Hour?

Adults and children 12 years and older should take one tablet every 12 hours. Children 6 to 11 years old should take half a tablet every 12 hours[4].

3. Can I take Zyrtec-D 12 Hour with food?

Yes, Zyrtec-D 12 Hour can be taken with or without food, as food does not significantly affect the absorption of either cetirizine or pseudoephedrine[1].

4. What are the common side effects of Zyrtec-D 12 Hour?

Common side effects include drowsiness, headache, dizziness, fatigue, dry mouth, and pseudoephedrine-specific side effects like insomnia and heart palpitations[2][3].

5. Is Zyrtec-D 12 Hour covered by insurance?

No, Zyrtec-D 12 Hour is generally not covered by insurance or Medicare Part D due to its over-the-counter status[2].

Sources:

  1. ZYRTEC-D 12 HOURâ„¢ - accessdata.fda.gov
  2. Zyrtec vs. Zyrtec-D: Differences, similarities, and which is better for you - SingleCare
  3. ZYRTEC-D 12 HOUR - accessdata.fda.gov
  4. The Ultimate Guide to Zyrtec D: Benefits, Side Effects, and Usage - Cabinet Health
  5. Zyrtec-D 12 Hour Allergy & Sinus Medicine & Nasal Decongestant - Costco

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.